Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zarah Glad Zimling"'
Publikováno v:
Lung Cancer Management. 2:295-307
SUMMARY Platinum-based chemotherapy regimens using cisplatin or carboplatin are the cornerstones of treatment for advanced non-small-cell lung cancer (NSCLC), small-cell lung cancer and malignant pleural mesothelioma. Despite being standard regimens
Autor:
Eric Santoni-Rugiu, Zarah Glad Zimling, Claus B. Andersen, Cecilia Bech, Jens Benn Sørensen, Thomas A. Gerds
Publikováno v:
University of Copenhagen
Malignant pleural mesothelioma (MPM) has a dismal prognosis. Treatment results may be improved by biomarker-directed therapy. We investigated the baseline expression and impact on outcome of predictive biomarkers ERCC1, BRCA1, and class III β-tubuli
Publikováno v:
Histopathology. 60:E96-E105
Zimling Z G, Jorgensen A & Santoni-Rugiu E (2012) Histopathology 60, E96–E105 The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas Aims: Malignant pleural mesotheliom
Autor:
Cecilia Bech, Zarah Glad Zimling, Claus B. Andersen, Eric Santoni-Rugiu, Jens Benn Sørensen, Thomas A. Gerds
Publikováno v:
Journal of Thoracic Oncology. 7:249-256
Introduction The relationship between excision repair cross-complementation group 1 (ERCC1) expression and outcome, in patients with malignant pleural mesothelioma (MPM), treated with cisplatin/vinorelbine combination-therapy, was retrospectively eva
Autor:
Ronald Simon, Maria Antonietta De Ioris, Lisa Leth Maroun, M Quarto, Henrik Daa Schrøder, Jens Vilstrup Johansen, Mette Rose Jørgensen, Eric Santoni-Rugiu, Kristian Helin, Guido Sauter, Zarah Glad Zimling, Bodil Laub Petersen, Julie Skotte, Michael Lees, Rossella Rota, Heidi Rye Hudlebusch, Catherine Rechnitzer
Publikováno v:
Hudlebusch, H R, Skotte, J, Santoni-Rugiu, E, Zimling, Z G, Lees, M J, Simon, R, Sauter, G, Rota, R, De Ioris, M A, Quarto, M, Johansen, J V, Jørgensen, M, Rechnitzer, C M A, Maroun, L L, Schrøder, H, Petersen, B L & Helin, K 2011, ' MMSET is highly expressed and associated with aggressiveness in neuroblastoma ', Cancer Research, vol. 71, no. 12, pp. 4226-35 . https://doi.org/10.1158/0008-5472.CAN-10-3810
MMSET (WHSC1/NSD2) is a SET domain–containing histone lysine methyltransferase the expression of which is deregulated in a subgroup of multiple myelomas with the t(4;14)(p16;q32) translocation associated with poor prognosis. Recent studies have sho
Publikováno v:
APMIS. 115:66-74
The peripheral neuroblastic tumour group includes neuroblastoma, ganglioneuroblastoma and ganglioneuroma. Neuroblastoma is the most common extracranial solid tumour of childhood. We have evaluated the histological presentation, MYCN gene status, and
Publikováno v:
Publons
University of Copenhagen
University of Copenhagen
A possible predictive impact of ribonucleotide-reductase subunit-1 (RRM1) on vinorelbine efficacy in non-small cell lung cancer (NSCLC) has been previously reported. The present study aimed to further explore this finding in malignant pleural mesothe
Publikováno v:
APMIS. 112:153-158
Neuroblastoma is one of the most common malignant neoplasms in childhood. These tumours represent a heterogeneous group both in terms of clinical course and histological appearance, ranging from benign, slowly growing, often asymptomatic ganglioneuro
Publikováno v:
Histopathology. 60(6B)
Malignant pleural mesothelioma (MPM) often causes diagnostic difficulties for pathologists. We assessed whether loss of methylthioadenosine phosphorylase (MTAP), a key enzyme in the intracellular recycling of adenosine triphosphate (ATP) often delete